212: When the Innovator Becomes the Patient: Manufacturing Reality vs. Patient Urgency with Jesús...

What happens when cell therapy innovation meets real patient urgency? In this conversation, the barriers between scientist and patient all but vanish, bringing clarity—and a new sense of mission—to some of the biggest problems facing advanced therapy manufacturing and delivery.


Meet Jesús Zurdo, a biotech leader whose three decades of experience in innovation took on a whole new perspective when he became a leukemia patient himself. Seamlessly straddling the worlds of industry and patient care, Jesús Zurdo brings a refreshingly honest, systems-level view to cell therapies, manufacturing bottlenecks, and the realities of getting therapies from the lab to bedside.


Topics discussed:

• Experiences and lessons from stem cell registries and point-of-care manufacturing models (03:15)
• Challenges and potential of autologous and allogeneic cell therapies, including scalability and accessibility (06:08)
• The promise and limitations of in vivo cell therapy, delivery risks and patient safety (07:06)
• Reflections on current trends in manufacturing automation, delivery platforms, and the risk of overengineering (09:49)
• Barriers to wider adoption of advanced cell therapies, including hospital infrastructure and economic constraints (13:31)
• The case for earlier lines of treatment with new modalities and value in learning from actual patient experiences (14:30)
• The importance of integrating voices of patients, clinicians, and developers when solving complex problems (17:31)
• Why urgency and remembering our future roles as patients should guide therapy development (18:51)

Ready for bioprocessing to serve patients, yours included? For more insights and hands-on support, please subscribe so you never miss the next perspective-shifting episode.


Connect with Jesús Zurdo:


LinkedIn:   / jesuszurdo  


Email: [email protected] (mailto:[email protected])


Next step:


Book a 20-minute call to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/call


Support the show (https://www.buzzsprout.com/2263581/su...)